Filing Details

Accession Number:
0001209191-23-047102
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-23 17:56:22
Reporting Period:
2023-08-21
Accepted Time:
2023-08-23 17:56:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831828 Vera Therapeutics Inc. VERA Pharmaceutical Preparations (2834) 812744449
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1859453 Marshall Fordyce C/O Vera Therapeutics, Inc.
8000 Marina Boulevard, Suite 120
Brisbane CA 94005
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2023-08-21 5,210 $16.66 243,361 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units pursuant to an election intended to satisfy the conditions of Rule 10b5-1(c) made by the Reporting Person on August 26, 2022.
  2. The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.65 to $16.893, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. Includes shares acquired under the Issuer's Employee Stock Purchase Plan on September 13, 2022 for 1,085 shares, and on March 13, 2023 for 1,183 shares.